Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Arbilla

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
European Journal of Pharmacology|July 9, 1982
Concomitant decrease in [3H]imipramine binding in cat brain and platelets after chronic treatment with imipramineM Briley, R Raisman, S Arbilla, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1985
Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpineR Niddam, S Arbilla, B Scatton, et al.
Biochemical and Biophysical Research Communications|March 3, 1975
Purification by affinity chromatography of nicotonic and muscarinic hydrophobic proteins separated by Sephadex LH20F J Barrantes, S Arbilla, M C de Carlin, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1982
Noradrenergic neurotransmission in the brain of a convulsive mutant mouse, differences between the cerebral cortex and the brain stemY Maurin, S Arbilla, J Dedek, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1985
Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons diseaseH Schoemaker, C Pimoule, S Arbilla, et al.
Psychopharmacology. Supplementum|January 1, 1985
Influence of GABA mimetics and lithium on biochemical manifestations of striatal dopamine target cell hypersensitivityB Scatton, D Fage, A Oblin, et al.
European Journal of Pharmacology|May 24, 1995
Binding of [3H]cirazoline to an imidazoline site in rat brain and kidney membranesM Le Rouzic, I Angel, H Schoemaker, et al.
L'Encephale|January 1, 1990
[A specific domain (the omega 1 site) of the GABA(A) receptor may be implicated in the hypnotic effects of zolpidem]J Benavides, H Depoortere, D Sanger, et al.
Pharmacopsychiatry|May 1, 1990
Selectivity for omega-receptor subtypes as a strategy for the development of anxiolytic drugsS Z Langer, S Arbilla, S Tan, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1982
gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptorK G Lloyd, S Arbilla, K Beaumont, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
European Journal of Pharmacology|July 9, 1982
Concomitant decrease in [3H]imipramine binding in cat brain and platelets after chronic treatment with imipramineM Briley, R Raisman, S Arbilla, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 1, 1985
Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpineR Niddam, S Arbilla, B Scatton, et al.
Biochemical and Biophysical Research Communications|March 3, 1975
Purification by affinity chromatography of nicotonic and muscarinic hydrophobic proteins separated by Sephadex LH20F J Barrantes, S Arbilla, M C de Carlin, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1982
Noradrenergic neurotransmission in the brain of a convulsive mutant mouse, differences between the cerebral cortex and the brain stemY Maurin, S Arbilla, J Dedek, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1985
Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons diseaseH Schoemaker, C Pimoule, S Arbilla, et al.
Psychopharmacology. Supplementum|January 1, 1985
Influence of GABA mimetics and lithium on biochemical manifestations of striatal dopamine target cell hypersensitivityB Scatton, D Fage, A Oblin, et al.
European Journal of Pharmacology|May 24, 1995
Binding of [3H]cirazoline to an imidazoline site in rat brain and kidney membranesM Le Rouzic, I Angel, H Schoemaker, et al.
L'Encephale|January 1, 1990
[A specific domain (the omega 1 site) of the GABA(A) receptor may be implicated in the hypnotic effects of zolpidem]J Benavides, H Depoortere, D Sanger, et al.
Pharmacopsychiatry|May 1, 1990
Selectivity for omega-receptor subtypes as a strategy for the development of anxiolytic drugsS Z Langer, S Arbilla, S Tan, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1982
gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptorK G Lloyd, S Arbilla, K Beaumont, et al.
Pageof 7